跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

Elsevier
與我們共同出版
Press release

Elsevier launches Ebola Information Center with free clinical and research resources to support response to outbreak

2026年6月12日

Comprehensive resource center offers free access to clinical guidance, peer-reviewed research, early-stage research, datasets and AI-assisted research tools to support the global health emergency response

Following the World Health Organization’s declaration of an Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of Congo and Uganda as a Public Health Emergency of International Concern (PHEIC), Elsevier, a global leader in scientific information and analytics, has launched its Ebola Information Center to provide healthcare professionals, researchers, policy makers and the public with free access to critical clinical and research information to support the global response to this outbreak.

Elsevier’s Ebola Information Center brings together a wide range of freely available resources, with a focus on the emerging Bundibugyo virus variant. The center combines evidence-based clinical guidance, peer-reviewed research, early-stage research findings, datasets and AI-assisted research tools to support rapid evidence discovery and response coordination during this critical public health emergency.

Key Resources Available:

  • Ebola Healthcare Hub: A dedicated clinical resource offering evidence-based clinical overviews, patient education materials and drug monographs to support healthcare professionals responding to the outbreak

  • ScienceDirect Research Content: Ebola-related articles and book chapters published by Elsevier journals are freely available on ScienceDirect, the world’s leading platform of peer-reviewed scholarly literature. New content will continue to be made available throughout the duration of the crisis

  • LeapSpace: Researchers working on the outbreak response can access LeapSpace, the research-grade AI workspace to rapidly map existing evidence on Bundibugyo virus pathology, treatment approaches and outbreak response, identify relevant collaborators and funding opportunities, and analyse their own research data alongside published literature

  • The Lancet Ebola Collection: Ebola-related research, reviews and commentaries are being made freely available as they are published across The Lancet Group’s journals.

  • Cell Press Ebola Collection: Ebola research is being made freely available across Cell Press journals

  • SSRN Ebola Hub: Early-stage research on Bundibugyo virus is being made immediately available through SSRN, Elsevier’s platform for rapid worldwide dissemination of preprints. The curated Ebola Hub helps researchers, public health authorities, clinicians and the public access emerging findings. Please note that these papers have not yet benefited from peer review

  • Mendeley Data: Ebola-related datasets indexed across multiple repositories including figshare, Zenodo and Dryad have been curated to help researchers rapidly identify potentially relevant data for their work.

Esra Erkal, Executive Vice President of Global Communications for Elsevier, said: “The Ebola Information Center represents our commitment to supporting the global health emergency response by making critical scientific knowledge and clinical resources immediately and freely accessible to those on the frontlines of this outbreak. We will continuously expand the resources available as new evidence emerges.”

Elsevier has also made all the content from the Ebola Information Center available on publicly funded repositories, with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are provided free of charge for as long as the Ebola Information Center remains active.

Additional resources will be continuously added to the Ebola Information Center throughout the duration of the public health emergency. The company’s response to Ebola follows Elsevier’s previous support for global health emergencies including SARS, MERS, Zika, Coronavirus and Mpox, demonstrating a sustained commitment to supporting the scientific community and public health response during critical health crises.

關於 Elsevier

身為科學資訊與分析的全球領導者,Elsevier 協助研究人員與醫療照護專業人員推動科學發展,改善醫療成果,造福社會。我們以可信賴、以實證為基礎的內容和先進的 AI 數位技術為基礎,透過創新的解決方案促進洞察力和關鍵決策。

140 多年來,我們一直為研究和醫療保健界的工作提供支援。我們全球 9,500 名員工,包括 2,300 名技術人員,致力於支援研究人員、圖書館館長、學術領袖、資金提供者、政府、研發密集型公司、醫生、護士、未來醫療保健專業人員和教育工作者的重要工作。我們的 2,900 種科學期刊和經典參考工具書包括其領域中最重要的書籍,包括 Cell Press、The Lancet 和 Gray's Anatomy。 我們與愛思唯爾基金會 (Elsevier Foundationopens in new tab/window) 合作,與我們服務的社群攜手合作,在發展中國家和世界各地的科學、研究和醫療保健領域推動包容性和多樣性。 Elsevier 是 RELXopens in new tab/window 的一部分,RELXopens in new tab/window 是一家為專業和商業客戶提供以資訊為基礎的分析和決策工具的全球供應商。有關我們的工作、數位解決方案和內容的更多資訊,請造訪 www.elsevier.com

聯絡人

Portrait photo of Andrew Davis

Andrew Davis

歐洲企業溝通副總裁

Elsevier

+44 7393 242466

電子郵件 Andrew Davis